Cargando…

Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells

BACKGROUND: Drug resistance and metastasis involving hypoxic tumor environments and persistent stem cell populations are detrimental to the survival of patients with non-small cell lung carcinoma (NSCLC). Tie1 is upregulated in hypoxia and is believed to counteract the effectiveness of platinum agen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chaojie, Yang, Nannan, Chen, Zhijin, Xia, Ning, Shan, Qungang, Wang, Ziyin, Lu, Jian, Shang, Mingyi, Wang, Zhongmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814430/ https://www.ncbi.nlm.nih.gov/pubmed/33461544 http://dx.doi.org/10.1186/s12935-020-01729-3

Ejemplares similares

Treatment of aerodigestive fistulas with a novel covered metallic Y-shaped segmented airway stent customized with the assistance of 3D printing
por: Shan, Qungang, et al.
Publicado: (2021)

HNRNPC regulates RhoA to induce DNA damage repair and cancer‐associated fibroblast activation causing radiation resistance in pancreatic cancer
por: Xia, Ning, et al.
Publicado: (2022)

Preliminary Experience With a Novel Metallic Segmented Transcordal Stent Modified With Three-Dimensional Printing for Inoperable Malignant Laryngotracheal Stenosis
por: Shan, Qungang, et al.
Publicado: (2021)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells
por: Wang, Jing, et al.
Publicado: (2019)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
por: Gao, Yanyun, et al.
Publicado: (2019)

Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
por: Kapperman, Heather E., et al.
Publicado: (2018)

Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers
por: Liu, Xiaoyu, et al.
Publicado: (2022)

PESV represses non-small cell lung cancer cell malignancy through circ_0016760 under hypoxia
por: Zhang, Hong, et al.
Publicado: (2021)

CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)
por: Zhao, Yongsheng, et al.
Publicado: (2020)

MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer
por: Wang, Hui, et al.
Publicado: (2020)

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
por: Sun, Tingting, et al.
Publicado: (2021)

SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
por: Zhang, Yongli, et al.
Publicado: (2016)

The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance
por: Li, Tiezhi, et al.
Publicado: (2022)

Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia
por: Wei, Xiaokang, et al.
Publicado: (2016)

Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells
por: Osman, Abdel-Moneim M., et al.
Publicado: (2015)

NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells
por: Huang, Zhenhua, et al.
Publicado: (2003)

Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis
por: Li, Huiping, et al.
Publicado: (2020)

The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy
por: Xu, Zengguang, et al.
Publicado: (2014)

LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
por: Wu, Yue, et al.
Publicado: (2021)

Vγ9Vδ2 T cells strengthen cisplatin inhibition activity against breast cancer MDA-MB-231 cells by disrupting mitochondrial function and cell ultrastructure
por: Huang, Xin, et al.
Publicado: (2021)

Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis
por: Luo, Xiaoqiong, et al.
Publicado: (2019)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
por: Zhou, Yang, et al.
Publicado: (2022)

TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling
por: Pan, Shengli, et al.
Publicado: (2019)

Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway
por: Li, Sheng, et al.
Publicado: (2017)

FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression
por: Zhu, Yunheng, et al.
Publicado: (2020)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells
por: Daker, Maelinda, et al.
Publicado: (2012)

SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells
por: Xu, Zhaoying, et al.
Publicado: (2020)

Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis
por: Zhang, Furui, et al.
Publicado: (2021)

Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia
por: Liu, Xin, et al.
Publicado: (2014)

ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231
por: Zhang, Yuzhu, et al.
Publicado: (2018)

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein
por: Choi, Cheol-Hee, et al.
Publicado: (2004)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
por: Shayan, Sara, et al.
Publicado: (2022)

Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression
por: Calogero, Antonella, et al.
Publicado: (2011)

MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer
por: Li, Qinchuan, et al.
Publicado: (2015)

Involvement of human chorionic gonadotropin in regulating vasculogenic mimicry and hypoxia-inducible factor-1α expression in ovarian cancer cells
por: Su, Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0d4vblp3fa7e2cgoe0gqt5m0pi